Details for New Drug Application (NDA): 019037
✉ Email this page to a colleague
The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for 019037
Tradename: | IMODIUM |
Applicant: | Janssen Pharms |
Ingredient: | loperamide hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019037
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 1MG/5ML | ||||
Approval Date: | Jul 31, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 019037
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription